Contact

Our portfolio

Cellagenics

Cellagenics

Developing STEP® technology, Cellagenics scales up therapeutic antibody production in mammalian cell lines. Their collaboration with Batavia Biosciences aims to enhance biopharmaceutical manufacturing.

  • Institute: University of Amsterdam
Industry: Therapeutics
  • Founding year: 2008
Visit website

Want to get in contact about Cellagenics?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

Rsouth Antibodies
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
Hipper Therapeutics
Boosting recovery and confidence in elderly hip fracture patients with data-driven rehabilitation technology.
Plantics
Reducing plastic waste and lowering CO2 emissions.
Parkinnova Therapeutics
Developing novel treatments for Parkinson’s disease and dopamine disorders.
Rsouth Antibodies
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
Hipper Therapeutics
Boosting recovery and confidence in elderly hip fracture patients with data-driven rehabilitation technology.
Plantics
Reducing plastic waste and lowering CO2 emissions.
Parkinnova Therapeutics
Developing novel treatments for Parkinson’s disease and dopamine disorders.
Explore full AAV portfolio
Contact